chr12-8606214-G-T
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_020661.4(AICDA):c.156+651C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_020661.4 intron
Scores
Clinical Significance
Conservation
Publications
- hyper-IgM syndrome type 2Inheritance: AD, AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_020661.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| AICDA | NM_020661.4 | MANE Select | c.156+651C>A | intron | N/A | NP_065712.1 | |||
| AICDA | NM_001330343.2 | c.156+651C>A | intron | N/A | NP_001317272.1 | ||||
| AICDA | NM_001410970.1 | c.156+651C>A | intron | N/A | NP_001397899.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| AICDA | ENST00000229335.11 | TSL:1 MANE Select | c.156+651C>A | intron | N/A | ENSP00000229335.6 | |||
| AICDA | ENST00000543081.6 | TSL:1 | c.156+651C>A | intron | N/A | ENSP00000439103.2 | |||
| AICDA | ENST00000544516.6 | TSL:1 | c.156+651C>A | intron | N/A | ENSP00000439538.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at